These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 20858023
21. Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites. Presland J. Curr Opin Drug Discov Devel; 2005 Sep; 8(5):567-76. PubMed ID: 16159018 [Abstract] [Full Text] [Related]
23. Signal transduction via G protein coupled receptors: a personal outlook. Schlegel W. J Recept Signal Transduct Res; 2010 Dec; 30(6):493-9. PubMed ID: 21058935 [Abstract] [Full Text] [Related]
24. Membrane signalling complexes: implications for development of functionally selective ligands modulating heptahelical receptor signalling. Piñeyro G. Cell Signal; 2009 Feb; 21(2):179-85. PubMed ID: 18790047 [Abstract] [Full Text] [Related]
26. Allosteric drugs and seven transmembrane receptors. Kenakin T. Curr Top Med Chem; 2013 Jun; 13(1):5-13. PubMed ID: 23409762 [Abstract] [Full Text] [Related]
27. The plasticity of the 7TMR signaling machinery and the search for pharmacological selectivity. Flordellis CS. Curr Pharm Des; 2012 Jun; 18(2):145-60. PubMed ID: 22229579 [Abstract] [Full Text] [Related]
28. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation. Hoare SR, Fleck BA, Gross RS, Crowe PD, Williams JP, Grigoriadis DE. Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030 [Abstract] [Full Text] [Related]
29. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Kristiansen K. Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227 [Abstract] [Full Text] [Related]
30. Functional selectivity through protean and biased agonism: who steers the ship? Kenakin T. Mol Pharmacol; 2007 Dec; 72(6):1393-401. PubMed ID: 17901198 [Abstract] [Full Text] [Related]
36. The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor-receptor interactions. Fuxe K, Marcellino D, Borroto-Escuela DO, Frankowska M, Ferraro L, Guidolin D, Ciruela F, Agnati LF. J Recept Signal Transduct Res; 2010 Oct; 30(5):272-83. PubMed ID: 20684666 [Abstract] [Full Text] [Related]
37. G protein-coupled receptor oligomerization for what? Ciruela F, Vallano A, Arnau JM, Sánchez S, Borroto-Escuela DO, Agnati LF, Fuxe K, Fernández-Dueñas V. J Recept Signal Transduct Res; 2010 Oct; 30(5):322-30. PubMed ID: 20718634 [Abstract] [Full Text] [Related]
38. [G-protein-coupled receptors targeting: the allosteric approach]. Sebag JA, Pantel J. Med Sci (Paris); 2012 Oct; 28(10):845-51. PubMed ID: 23067415 [Abstract] [Full Text] [Related]
39. Inverse agonists: tools to reveal ligand-specific conformations of G protein-coupled receptors. Prather PL. Sci STKE; 2004 Jan 05; 2004(215):pe1. PubMed ID: 14722344 [Abstract] [Full Text] [Related]